Allspring Global Investments
GSK icon

Allspring Global Investments’s GSK GSK Stock Holding History

Allspring Global Investments’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.24M Buy
24,142
+1,661
+7% +$87.8K ﹤0.01% 1173
2026
Q1 		$1.27M Buy
22,481
+5,876
+35% +$318K ﹤0.01% 1132
2025
Q4 		$817K Buy
16,605
+5,442
+49% +$254K ﹤0.01% 1219
2025
Q3 		$496K Sell
11,163
-1,741
-13% -$68K ﹤0.01% 1352
2025
Q2 		$500K Buy
12,904
+491
+4% +$18.8K ﹤0.01% 1348
2025
Q1 		$464K Buy
12,413
+1,248
+11% +$45.7K ﹤0.01% 1472
2024
Q4 		$374K Sell
11,165
-599
-5% -$21.6K ﹤0.01% 1526
2024
Q3 		$481K Buy
11,764
+3,405
+41% +$139K ﹤0.01% 1485
2024
Q2 		$322K Sell
8,359
-5,187
-38% -$218K ﹤0.01% 1610
2024
Q1 		$581K Buy
13,546
+4,126
+44% +$170K ﹤0.01% 1493
2023
Q4 		$349K Hold
9,420
– – ﹤0.01% 1576
2023
Q3 		$341K Hold
9,420
– – ﹤0.01% 1610
2023
Q2 		$336K Buy
9,420
+3,100
+49% +$111K ﹤0.01% 1659
2023
Q1 		$225K Hold
6,320
– – ﹤0.01% 1787
2022
Q4 		$222K Hold
6,320
– – ﹤0.01% 1802
2022
Q3 		$185K Hold
6,320
– – ﹤0.01% 1846
2022
Q2 		$343K Hold
6,320
– – ﹤0.01% 1671
2022
Q1 		$344K Sell
6,320
-2,320
-27% -$126K ﹤0.01% 2386
2021
Q4 		$476K Buy
+8,640
New +$449K ﹤0.01% 2316

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Allspring Global Investments's GSK Position: Q2 2026 in Review

Allspring Global Investments increased its GSK (GSK) stake by 7.4% in Q2 2026, buying an estimated $87.8K and bringing the position to 24,142 shares worth $1.24M. The position accounts for ﹤0.01% of the portfolio, ranked #1173.

Allspring Global Investments first reported a position in GSK in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.27M in Q1 2026. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Allspring Global Investments held 24,142 shares of GSK worth $1.24M as of Q2 2026.
  • Allspring Global Investments bought 1,661 GSK shares in Q2 2026, an estimated $87.8K.
  • GSK made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1173 holding.
  • Allspring Global Investments first reported a position in GSK in Q4 2021 and has held it in 19 quarters since.
  • Allspring Global Investments's GSK position peaked at $1.27M in Q1 2026.
  • 1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.